Epperly Melissa B, insider trades: Roivant Sciences (ROIV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Epperly Melissa B, reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ROIV | ↓ Sell10b5-1 | 17,750 | $36.10 | $641K | Direct | Oct 5, 2026 (4d) |
| Sep 15, 2026 | ROIV | ↓ Sell | 4,938 | $39.74 | $196K | Direct | Sep 17, 2026 (2d) |
| Jun 29, 2026 | ROIV | ↓ Sell | 17,750 | $34.38 | $610K | Direct | Jul 1, 2026 (2d) |
| Mar 16, 2026 | ROIV | ↓ Sell | 41,861 | $28.68 | $1.2M | Direct | Mar 18, 2026 (2d) |
| Feb 12, 2024 | ZNTL | ↓ Sell | 2,573 | $11.44 | $29K | Direct | Feb 12, 2024 (0d) |
| Feb 2, 2024 | ZNTL | ↓ Sell | 8,669 | $11.54 | $100K | Direct | Feb 5, 2024 (3d) |
| Oct 4, 2023 | ZNTL | ↓ Sell | 5,482 | $19.50 | $107K | Direct | Oct 6, 2023 (2d) |
| Feb 14, 2023 | ZNTL | ↓ Sell | 7,851 | $20.13 | $158K | Direct | Feb 14, 2023 (0d) |
| Apr 4, 2022 | ZNTL | ↓ Sell | 17,080 | $50.09 | $856K | Direct | Apr 5, 2022 (1d) |
| Feb 23, 2022 | ZNTL | ↓ Sell | 1,913 | $49.10 | $94K | Direct | Feb 23, 2022 (0d) |
| Aug 19, 2021 | ZNTL | ↑ Buy | 9,611 | $52.00 | $500K | Direct | Aug 20, 2021 (1d) |
| Jul 1, 2021 | ZNTL | ↓ Sell | 3,083 | $51.27 | $158K | Direct | Jul 6, 2021 (5d) |
| Jun 1, 2021 | ZNTL | ↓ Sell | 3,083 | $54.05 | $167K | Direct | Jun 2, 2021 (1d) |
| May 3, 2021 | ZNTL | ↓ Sell | 3,083 | $59.24 | $183K | Direct | May 5, 2021 (2d) |
| Apr 5, 2021 | ZNTL | ↓ Sell | 17,107 | $43.39 | $742K | Direct | Apr 6, 2021 (1d) |
| Mar 1, 2021 | ZNTL | ↓ Sell | 3,083 | $41.67 | $128K | Direct | Mar 3, 2021 (2d) |
| Feb 1, 2021 | ZNTL | ↓ Sell | 3,083 | $37.56 | $116K | Direct | Feb 3, 2021 (2d) |
| Jan 4, 2021 | ZNTL | ↓ Sell | 3,083 | $51.91 | $160K | Direct | Jan 6, 2021 (2d) |
| Dec 7, 2020 | ZNTL | ↓ Sell | 13,684 | $52.18 | $714K | Direct | Dec 8, 2020 (1d) |
| Dec 2, 2020 | ZNTL | ↓ Sell | 3,083 | $51.47 | $159K | Direct | Dec 3, 2020 (1d) |
| Nov 23, 2020 | ZNTL | ↓ Sell | 3,083 | $46.58 | $144K | Direct | Nov 25, 2020 (2d) |
| Apr 7, 2020 | ZNTL | ↑ Buy | 20,000 | $18.00 | $360K | Direct | Nov 25, 2020 (232d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ROIV insiders
Open-market trades in the last 12 months
About Epperly Melissa B,'s insider trades
Epperly Melissa B, is a director at Roivant Sciences (ROIV). Since Apr 7, 2020, it has reported 2 open-market purchases worth $860K and 20 sales worth $6.7M on SEC Form 4. In the last 12 months: 4 sales ($2.6M).
1 sale (10% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Its filings also include grants and awards (33 filings), shares withheld for taxes (6 filings), option exercises (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.